Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of Insulin-like Growth Factor Receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231

Desma M. Grice, Irina Vetter, Helen M. Faddy, Paraic A. Kenny, Sarah J. Roberts-Thomson, Gregory R. Monteith

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Calcium signaling is a key regulator of pathways important in tumor progression, such as proliferation and apoptosis. Most studies assessing altered calcium homeostasis in cancer cells have focused on alterations mediated through changes in cytoplasmic free calcium levels. Here, we show that basal-like breast cancers are characterized by an alteration in the secretory pathway calcium ATPase 1 (SPCA1), a calcium pump localized to the Golgi. Inhibition of SPCA1 in MDA-MB-231 cells produced pronounced changes in cell proliferation and morphology in three-dimensional culture, without alterations in sensitivity to endoplasmic reticulum stress induction or changes in global calcium signaling. Instead, the effects of SPCA1 inhibition in MDA-MB-231 cells reside in altered regulation of calcium-dependent enzymes located in the secretory pathway, such as proprotein convertases. Inhibition of SPCA1 produced a pronounced alteration in the processing of insulin-like growth factor receptor (IGF1R), with significantly reduced levels of functional IGF1Rβ and accumulation of the inactive trans-Golgi network pro-IGF1R form. These studies identify for the first time a calcium transporter associated with the basal-like breast cancer subtype. The pronounced effects of SPCA1 inhibition on the processing of IGF1R in MDA-MB-231 cells independent of alterations in global calcium signaling also demonstrate that some calcium transporters can regulate the processing of proteins important in tumor progression without major alterations in cytosolic calcium signaling. Inhibitors of SPCA1 may offer an alternative strategy to direct inhibitors of IGF1R and attenuate the processing of other proprotein convertase substrates important in basal breast cancers.

Original languageEnglish (US)
Pages (from-to)37458-37466
Number of pages9
JournalJournal of Biological Chemistry
Volume285
Issue number48
DOIs
StatePublished - Nov 26 2010

Fingerprint

Somatomedin Receptors
Calcium-Transporting ATPases
Secretory Pathway
Cells
Pumps
Breast Neoplasms
Calcium Signaling
Calcium
Cell Line
Processing
Proprotein Convertases
trans-Golgi Network
Neoplasms
Endoplasmic Reticulum Stress
Tumors
Homeostasis
Cell proliferation
Cell Proliferation
Apoptosis
Cell culture

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of Insulin-like Growth Factor Receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. / Grice, Desma M.; Vetter, Irina; Faddy, Helen M.; Kenny, Paraic A.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.

In: Journal of Biological Chemistry, Vol. 285, No. 48, 26.11.2010, p. 37458-37466.

Research output: Contribution to journalArticle

Grice, Desma M. ; Vetter, Irina ; Faddy, Helen M. ; Kenny, Paraic A. ; Roberts-Thomson, Sarah J. ; Monteith, Gregory R. / Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of Insulin-like Growth Factor Receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. In: Journal of Biological Chemistry. 2010 ; Vol. 285, No. 48. pp. 37458-37466.
@article{6758efffd751401d85ed9ff39f480031,
title = "Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of Insulin-like Growth Factor Receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231",
abstract = "Calcium signaling is a key regulator of pathways important in tumor progression, such as proliferation and apoptosis. Most studies assessing altered calcium homeostasis in cancer cells have focused on alterations mediated through changes in cytoplasmic free calcium levels. Here, we show that basal-like breast cancers are characterized by an alteration in the secretory pathway calcium ATPase 1 (SPCA1), a calcium pump localized to the Golgi. Inhibition of SPCA1 in MDA-MB-231 cells produced pronounced changes in cell proliferation and morphology in three-dimensional culture, without alterations in sensitivity to endoplasmic reticulum stress induction or changes in global calcium signaling. Instead, the effects of SPCA1 inhibition in MDA-MB-231 cells reside in altered regulation of calcium-dependent enzymes located in the secretory pathway, such as proprotein convertases. Inhibition of SPCA1 produced a pronounced alteration in the processing of insulin-like growth factor receptor (IGF1R), with significantly reduced levels of functional IGF1Rβ and accumulation of the inactive trans-Golgi network pro-IGF1R form. These studies identify for the first time a calcium transporter associated with the basal-like breast cancer subtype. The pronounced effects of SPCA1 inhibition on the processing of IGF1R in MDA-MB-231 cells independent of alterations in global calcium signaling also demonstrate that some calcium transporters can regulate the processing of proteins important in tumor progression without major alterations in cytosolic calcium signaling. Inhibitors of SPCA1 may offer an alternative strategy to direct inhibitors of IGF1R and attenuate the processing of other proprotein convertase substrates important in basal breast cancers.",
author = "Grice, {Desma M.} and Irina Vetter and Faddy, {Helen M.} and Kenny, {Paraic A.} and Roberts-Thomson, {Sarah J.} and Monteith, {Gregory R.}",
year = "2010",
month = "11",
day = "26",
doi = "10.1074/jbc.M110.163329",
language = "English (US)",
volume = "285",
pages = "37458--37466",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "48",

}

TY - JOUR

T1 - Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of Insulin-like Growth Factor Receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231

AU - Grice, Desma M.

AU - Vetter, Irina

AU - Faddy, Helen M.

AU - Kenny, Paraic A.

AU - Roberts-Thomson, Sarah J.

AU - Monteith, Gregory R.

PY - 2010/11/26

Y1 - 2010/11/26

N2 - Calcium signaling is a key regulator of pathways important in tumor progression, such as proliferation and apoptosis. Most studies assessing altered calcium homeostasis in cancer cells have focused on alterations mediated through changes in cytoplasmic free calcium levels. Here, we show that basal-like breast cancers are characterized by an alteration in the secretory pathway calcium ATPase 1 (SPCA1), a calcium pump localized to the Golgi. Inhibition of SPCA1 in MDA-MB-231 cells produced pronounced changes in cell proliferation and morphology in three-dimensional culture, without alterations in sensitivity to endoplasmic reticulum stress induction or changes in global calcium signaling. Instead, the effects of SPCA1 inhibition in MDA-MB-231 cells reside in altered regulation of calcium-dependent enzymes located in the secretory pathway, such as proprotein convertases. Inhibition of SPCA1 produced a pronounced alteration in the processing of insulin-like growth factor receptor (IGF1R), with significantly reduced levels of functional IGF1Rβ and accumulation of the inactive trans-Golgi network pro-IGF1R form. These studies identify for the first time a calcium transporter associated with the basal-like breast cancer subtype. The pronounced effects of SPCA1 inhibition on the processing of IGF1R in MDA-MB-231 cells independent of alterations in global calcium signaling also demonstrate that some calcium transporters can regulate the processing of proteins important in tumor progression without major alterations in cytosolic calcium signaling. Inhibitors of SPCA1 may offer an alternative strategy to direct inhibitors of IGF1R and attenuate the processing of other proprotein convertase substrates important in basal breast cancers.

AB - Calcium signaling is a key regulator of pathways important in tumor progression, such as proliferation and apoptosis. Most studies assessing altered calcium homeostasis in cancer cells have focused on alterations mediated through changes in cytoplasmic free calcium levels. Here, we show that basal-like breast cancers are characterized by an alteration in the secretory pathway calcium ATPase 1 (SPCA1), a calcium pump localized to the Golgi. Inhibition of SPCA1 in MDA-MB-231 cells produced pronounced changes in cell proliferation and morphology in three-dimensional culture, without alterations in sensitivity to endoplasmic reticulum stress induction or changes in global calcium signaling. Instead, the effects of SPCA1 inhibition in MDA-MB-231 cells reside in altered regulation of calcium-dependent enzymes located in the secretory pathway, such as proprotein convertases. Inhibition of SPCA1 produced a pronounced alteration in the processing of insulin-like growth factor receptor (IGF1R), with significantly reduced levels of functional IGF1Rβ and accumulation of the inactive trans-Golgi network pro-IGF1R form. These studies identify for the first time a calcium transporter associated with the basal-like breast cancer subtype. The pronounced effects of SPCA1 inhibition on the processing of IGF1R in MDA-MB-231 cells independent of alterations in global calcium signaling also demonstrate that some calcium transporters can regulate the processing of proteins important in tumor progression without major alterations in cytosolic calcium signaling. Inhibitors of SPCA1 may offer an alternative strategy to direct inhibitors of IGF1R and attenuate the processing of other proprotein convertase substrates important in basal breast cancers.

UR - http://www.scopus.com/inward/record.url?scp=78549245562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78549245562&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110.163329

DO - 10.1074/jbc.M110.163329

M3 - Article

C2 - 20837466

AN - SCOPUS:78549245562

VL - 285

SP - 37458

EP - 37466

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 48

ER -